Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The high cost may be a barrier for patients without adequate insurance coverage
R., & Hagen, T
A 2023 analysis by the Institute for Clinical and Economic Review suggests that GLP-1 drugs are cost-effective in the long run, considering the reduced expenses related to obesity complications
Most patients start at a lower dose to allow their body to adjust before gradually increasing it as needed
For 0.25 mg dose, draw 10 units (0.1ml) on insulin syringe
This single step reduces injection discomfort more than almost any other technique adjustment
US$ 22.66
US$ 22.16
US$ 22.17
US$ 21.67
US$ 26.55
